EUVIMEDEUVIMED entdecken
Crossref

A physiological concentration of anandamide promotes the migration of human endometrial fibroblast and the interaction with endothelial cells in vitro

Vanesa A Cañumil, Fernanda L de la Cruz Borthiry, Frida Scheffer, Yamila Herrero, Leopoldina Scotti, María Eugenia Bogetti, Fernanda Parborell, Gabriela F Meresman, Ana M Franchi, Jimena S Beltrame, María L Ribeiro

Placenta · 2023

DOI: 10.1016/j.placenta.2023.06.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Placenta, 2023. Verfasst von Vanesa A Cañumil und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Fisiología y Farmacología de la Reproducción, Centro de Estudios Farmacológicos y Botánicos (CEFYBO), CONICET-UBA, Paraguay 2155, CP(1…. Hauptthemen laut MEDLINE: Endocannabinoids, Endothelial Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The mechanisms that govern fibroblast behavior during the vascular adaptations of the uterus at early pregnancy remain unknown. Anandamide, an endocannabinoid, binds to cannabinoid receptors (CBs), and regulates gestation and angiogenesis. Its tone is regulated by fatty acid amide hydrolase (FAAH) within the uterus. We investigated the role of anandamide in endometrial fibroblasts migration and whether anandamide modulates fibroblasts-endothelial crosstalk. METHODS: T-hESC and EA.hy926 cell lines were used as models of endometrial stromal and endothelial cells, respectively. T-hESC were incubated with anandamide plus different agents. Migration was tested (wound healing assay and phalloidin staining). Protein expression and localization were studied by Western blot and immunofluorescence. To test fibroblast-endothelial crosstalk, EA.hy926 cells were incubated with fibroblast conditioned media obtained after T-hESC migration. RESULTS: Anandamide 1 nM increased T-hESC migration via CB1 and CB2. Cyclooxygenase-2 participated in anandamide-stimulated fibroblast migration. Prostaglandin F2alpha, and not prostaglandin E2, increased fibroblast wound closure. CB1, CB2, cyclooxygenase-2 and FAAH were expressed in T-hESC. Anandamide did not alter cyclooxygenase-2 localization but induced its cytoplasmic and nuclear expression through CB1 and CB2. URB-597, a FAAH selective inhibitor, also increased T-hESC migration via both CBs, and augmented cyclooxygenase-2 expression. Conditioned media from anandamide-induced T-hESC wound healing closure stimulated endothelial migration and did not alter their proliferation. Soluble factors from cyclooxygenase-2 were secreted by T-hESC and participated in T-hESC-induced EA.hy926 migration. Although anandamide-conditioned media augmented in EA.hy926 the expression of γH2AX, a marker of DNA damage, cyclooxygenase-2 was not involved in this effect. DISCUSSION: Our results provide novel evidence about an active role of anandamide on endometrial fibroblast behavior as a mechanism regulating uterine vascular adaptations in early gestation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndocannabinoidsEndothelial CellsPregnancyFemaleHumansCulture Media, ConditionedProstaglandin-Endoperoxide SynthasesFibroblastsAmidohydrolasesArachidonic AcidsPolyunsaturated Alkamides

Stichwörter der Autor:innen

AnandamideEndometriumEndothelial cellsMigrationStromal fibroblastsVascular remodeling

Substanzen

EndocannabinoidsCulture Media, ConditionedProstaglandin-Endoperoxide SynthasesAmidohydrolasesanandamideArachidonic AcidsPolyunsaturated Alkamides

Autor:innen und Institutionen

  • Laboratorio de Fisiología y Farmacología de la Reproducción, Centro de Estudios Farmacológicos y Botánicos (CEFYBO), CONICET-UBA, Paraguay 2155, CP(1121ABG), CABA, Argentina.
  • Laboratorio de Estudios de la Fisiopatología del Ovario, Instituto de Biología y Medicina Experimental (IByME), CONICET, Vuelta de Obligado 2490, CP (C1428ADN), CABA, Argentina.
  • Laboratorio de Fisiopatología Endometrial, Instituto de Biología y Medicina Experimental (IByME), CONICET, Vuelta de Obligado 2490, CP (C1428ADN), CABA, Argentina.
  • Laboratorio de Fisiopatología de la Preñez y el Parto, Centro de Estudios Farmacológicos y Botánicos (CEFYBO), CONICET-UBA, CABA, Argentina.
  • Laboratorio de Fisiología y Farmacología de la Reproducción, Centro de Estudios Farmacológicos y Botánicos (CEFYBO), CONICET-UBA, Paraguay 2155, CP(1121ABG), CABA, Argentina. Electronic address: mribeiro@fmed.uba.ar.

Zitieren

APA

Cañumil, V. A., de la Cruz Borthiry, F. L., Scheffer, F., Herrero, Y., Scotti, L., Bogetti, M. E., Parborell, F., Meresman, G. F., Franchi, A. M., Beltrame, J. S., & Ribeiro, M. L. (2023). A physiological concentration of anandamide promotes the migration of human endometrial fibroblast and the interaction with endothelial cells in vitro. Placenta. https://doi.org/10.1016/j.placenta.2023.06.004

Vancouver

Cañumil VA, de la Cruz Borthiry FL, Scheffer F, Herrero Y, Scotti L, Bogetti ME, et al. A physiological concentration of anandamide promotes the migration of human endometrial fibroblast and the interaction with endothelial cells in vitro. Placenta. 2023. doi:10.1016/j.placenta.2023.06.004

BibTeX
@article{Caumil2023,
  author = {Cañumil, Vanesa A and de la Cruz Borthiry, Fernanda L and Scheffer, Frida and Herrero, Yamila and Scotti, Leopoldina and Bogetti, María Eugenia and Parborell, Fernanda and Meresman, Gabriela F and Franchi, Ana M and Beltrame, Jimena S and Ribeiro, María L},
  title = {A physiological concentration of anandamide promotes the migration of human endometrial fibroblast and the interaction with endothelial cells in vitro},
  journal = {Placenta},
  year = {2023},
  doi = {10.1016/j.placenta.2023.06.004}
}
Kostenlos starten →